BitFan
Public Service Atlas for Bittensor
BitFan
NOVA 是一个药物研发科研平台，研究人员和技术团队在此竞相更快地找到有前景的分子或更优的分子搜索算法，不过实际操作主要通过代码和公开控制台进行，而非一站式的制药应用。
NOVA 是一个药物研发科研平台，研究人员和技术团队在此竞相更快地找到有前景的分子或更优的分子搜索算法，不过实际操作主要通过代码和公开控制台进行，而非一站式的制药应用。
- 成熟度：已上线 - 原因：技术用户可以查看公开控制台、按照 GitHub 说明进行配置并访问公开的模型发布，尽管尚无打磨完善的企业级自助应用。
The real target users are computational chemists, AI drug-discovery researchers, bioinformatics teams, and technical builders. The business-side audience may include biotech and pharma partners, but public commercial evidence is limited.
What is usable today includes the public website, dashboard, whitepapers, codebase, and public model releases. What remains incomplete is a normal enterprise buying path: no public price sheet, no self-serve API, no full customer list, and no public revenue/profit/funding disclosure.
Closest alternatives include Recursion, Insilico Medicine, Chai Discovery, Schrödinger, and Iambic Therapeutics. NOVA appears stronger in openness and inspectability, but weaker in clinical/commercial validation and established customer proof.
NOVA is a real and active AI drug-discovery research platform. It is usable by technical participants today. It is promising, but still early compared with established AI-drug-discovery companies.
